NeuroTech Portfolio Overview

 

Here you can get yourself acquainted with the neurotech companies that are of great investment interest based on their market performances and technology implemented. We also provide an introspective analysis of returns for different types of portfolios constructed out of these companies.

Companies Cumulative Capitalization Dynamics
(January 2020- June 2021), $ billion

Stabilizers 12 Months Return

Stabilizers are big, well-known companies with great market performance. This set is considered to be the most reliable and is suitable for risk-averse investors because of the companies inside have only positive average returns over the past 12 months. Considering the leitmotif of our portfolios, the companies chosen are also NeuroTech-related in their projects, collaborations and other market actions. 

Ipsen
Nevro
Cortexyme
Evotec
Prothena
Itamar Medical
Cerecor

Biohaven Pharmaceutical

Aldeyra Therapeutics

Clearside Biomedical

Equally-weighted Portfolio

75.77%

Min. Variance-adjusted Portfolio

34.91%

Capitalization-weighted Portfolio

30.52%

Sharpe-based Portfolio

134.17%

Portfolio overall performance

dkv-white.png